Copyright
©The Author(s) 2021.
World J Gastroenterol. Jun 14, 2021; 27(22): 3010-3021
Published online Jun 14, 2021. doi: 10.3748/wjg.v27.i22.3010
Published online Jun 14, 2021. doi: 10.3748/wjg.v27.i22.3010
Title | Ref. | Target | Result |
Microbial bile acid metabolites modulate gut RORγ+ regulatory T cell homeostasis | Song et al[83], 2020 | BA nuclear receptors | Restoration of the intestinal BA pool can increase colonic RORγ+ Treg cell counts and ameliorate host susceptibility to inflammatory colitis |
Bile acid metabolites control Th17 and Treg cell differentiation | Hang et al[48], 2019 | Derivatives of LCA, 3-oxoLCA and isoalloLCA | Administration of 3-oxoLCA and isoalloLCA to mice reduced Th17 cell differentiation and increased Treg cell differentiation, respectively, in the intestinal lamina propria |
Bile acids control inflammation and metabolic disorder through inhibition of NLRP3 inflammasome | Guo et al[26], 2016 | Membrane receptor TGR5 | Bile acids inhibited activation of the NLRP3 inflammasome via the TGR5-cAMP-PKA axis. |
Gut microbiome–mediated bile acid metabolism regulates liver cancer via NKT cells | Ma et al[10], 2018 | Hepatic CXCR6+ NKT cells | Microbiome uses bile acids as a messenger to accumulate NKT cells, which have an activated phenotype and inhibit liver tumor growth. |
TGR5 activation inhibits atherosclerosis by reducing macrophage inflammation and lipid loading | Pols et al[77], 2011 | Membrane receptor TGR5 | TGR5 activation in macrophages by 6a-ethyl-23(S)-methylcholic acid (6-EMCA, INT-777), a semisynthetic BA, inhibits proinflammatory cytokine production, an effect mediated by TGR5-induced cAMP signaling and subsequent NF-κB inhibition. |
- Citation: Shao JW, Ge TT, Chen SZ, Wang G, Yang Q, Huang CH, Xu LC, Chen Z. Role of bile acids in liver diseases mediated by the gut microbiome. World J Gastroenterol 2021; 27(22): 3010-3021
- URL: https://www.wjgnet.com/1007-9327/full/v27/i22/3010.htm
- DOI: https://dx.doi.org/10.3748/wjg.v27.i22.3010